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Abstract: Magnesium gluconate is widely used pharmaceutical/nutraceutical compound for the prevention and treatment of 
magnesium deficiency diseases. The present study was designed to explore the effect of The Trivedi Effect
®
 - Energy of 
Consciousness Healing Treatment (Biofield Energy Healing Treatment) on magnesium gluconate for the change in the 
structural properties and isotopic abundance ratio (PM+1/PM and PM+2/PM) using LC-MS and NMR spectroscopy. Magnesium 
gluconate was divided into two parts – one part was control, and another part was treated with The Trivedi Effect
®
 - Energy of 
Consciousness Healing Treatment remotely by twenty renowned Biofield Energy Healers and defined as The Trivedi Effect
®
 
treated sample. The LC-MS analysis of both the control and Biofield Energy Treated samples indicated the presence of mass of 
the protonated magnesium gluconate at m/z 415 at the retention time of 1.52 min and fragmentation pattern of both samples 
were almost identical. The relative peak intensities of the fragment ions were significantly altered in the treated sample 
compared to the control sample. The proton and carbon signals for CH, CH2 and CO groups in the proton and carbon NMR 
spectra of the control and treated samples were found same. The percentage change in the isotopic abundance ratio of PM+1/PM 
(
2
H/
1
H or 
13
C/
12
C or 
17
O/
16
O or 
25
Mg/
24
Mg) was significantly decreased in the treated sample by 48.87% compared to the 
control sample. Subsequently, the isotopic abundance ratio of PM+2/PM (
18
O/
16
O or 
26
Mg/
24
Mg) in the treated sample was 
significantly increased by 29.18% compared with the control sample. In summary, 
13
C, 
2
H, 
17
O, and 
25
Mg contributions from 
(C12H23MgO14)
+
 to m/z 416; 
18
O and 
26
Mg contributions from (C12H23MgO14)
+
 to m/z 417 in the treated sample were 
significantly altered compared with the control sample. Thus, The Trivedi Effect
®
 Treated magnesium gluconate might be 
helpful to design the novel potent enzyme inhibitors using its kinetic isotope effects. Consequently, The Trivedi Effect
®
 
Treated magnesium gluconate would be valuable for designing better pharmaceutical and/or nutraceutical formulations through 
its altered physicochemical and thermal properties, which might be providing better therapeutic response against various 
diseases such as diabetes mellitus, allergy, aging, inflammatory diseases, immunological disorders, and other chronic 
infections. 
23 Mahendra Kumar Trivedi et al.:  LC-MS and NMR Based Structural Characterization and Isotopic Abundance Ratio  
Analysis of Magnesium Gluconate Treated with the Consciousness Energy Healing 
Keywords: Magnesium Gluconate, The Trivedi Effect®, Consciousness Energy Healing Treatment,  
Biofield Energy Healing Treatment, Isotope Effects, Biofield Energy Healers, LC-MS, Isotopic Abundance 
 
1. Introduction 
Magnesium gluconate is an organometallic salt of 
magnesium with gluconic acid for the source of 
magnesium ion [1]. Magnesium is an essential mineral in 
our body, as it acts as cofactor for more than 300 enzymes, 
synthesis of DNA, RNA, reproduction, and protein as well 
as an important coherent controller of glycolysis and the 
Krebs cycle [2, 3]. Hypomagnesemia may cause several 
diseases and disorders [4-7]. Magnesium gluconate is 
found to be the most physiologically acceptable salt, 
antioxidant and exhibited the highest level of 
bioavailability of magnesium among the available 
magnesium salts [8-10]. Therefore, magnesium gluconate 
is used for the prevention and treatment of diabetes 
mellitus, allergies, cardiovascular diseases, septic shock, 
inflammatory diseases, immunological disorders, 
arrhythmias, acute myocardial infarction, gestational 
hypertension, preeclampsia, eclampsia, Alzheimer's 
disease, cancer, and oxidative stress induced 
ischemia/reperfusion injury [4-7, 9-11]. It can be used as 
neuroprotective [12], an oral tocolytic agent [13], and also 
in a skin-tightening cosmetic composition [14]. In this 
point of view, a novel proprietary herbomineral 
formulation was designed as a nutraceutical supplement, 
and can be used for the prevention and treatment of various 
human disorders. Magnesium gluconate is one of the 
components in this novel proprietary herbomineral 
formulation as the source of magnesium. 
Since ancient times, many different cultures, religions 
and systems of belief have recognized a living force that 
preserves and inhabits every living organism. This force is 
the source of ‘life’ and has been called various names, such 
as prana by the Hindus, qi or chi by the Chinese, and ki by 
the Japanese. This is believed to co-relate with the soul, 
spirit and mind. This hypothetical vital force has been 
scientifically evaluated and is now considered the 
Bioenergetics Field. The Biofield Energy is a dynamic 
electromagnetic field surrounding the human body, 
resulting from the continuous emission of low-level light, 
heat, and acoustical energy from the body. Biofield Energy 
is infinite, para-dimensional and can freely flow between 
the human and environment [15]. F. Sances et al. reported 
that Biofield Energy can be transmitted into any living 
organism (s) or nonliving object (s) around the globe with 
scientifically measurable effect through the intentional 
mental energies by specific energy healers [16]. The object 
or recipient always receives the energy from the 
ionosphere of the earth, the “universal energy field” and 
responds in a useful way. This process is known as The 
Trivedi Effect
®
 - Energy of Consciousness Healing 
Treatment [17, 18]. Biofield (Putative Energy Field) based 
Energy Therapies are used worldwide to promote health 
and healing. The National Center of Complementary and 
Integrative Health (NCCIH) has recognized and accepted 
Biofield Energy Healing as a Complementary and 
Alternative Medicine (CAM) health care approach in 
addition to other therapies, medicines and practices such as 
natural products, deep breathing, yoga, Tai Chi, Qi Gong, 
chiropractic/osteopathic manipulation, meditation, 
massage, special diets, homeopathy, progressive relaxation, 
guided imagery, acupressure, acupuncture, relaxation 
techniques, hypnotherapy, healing touch, movement 
therapy, pilates, rolfing structural integration, mindfulness, 
Ayurvedic medicine, traditional Chinese herbs and 
medicines, naturopathy, essential oils, aromatherapy, Reiki, 
cranial sacral therapy and applied prayer (as is common in 
all religions, like Christianity, Hinduism, Buddhism and 
Judaism) [19]. Biofield Energy Treatment (The Trivedi 
Effect
®
) has been drawn attention more in the recent times 
for its scientifically measurable capability to transform the 
characteristic properties of a wide varieties living and non-
living substances such as plants [20, 21], animals [22], 
microbes [23, 24], cancer cells [25], medium [26, 27], 
materials [28, 29], pharmaceuticals [30, 31], nutraceuticals 
[32, 33], organic compounds [34, 35]. The scientific study 
indicated that Biofield Energy Healing Treatment (The 
Trivedi Effect
®
) might be an alternate method for 
increasing or decreasing the natural isotopic abundance 
ratio of the substances [36-39]. The stable isotope ratio 
analysis has the broad application in several scientific 
fields for understanding the isotope effects resulting from 
the difference of the isotopic composition of the molecule 
[40, 41]. Conventional mass spectrometry (MS) techniques 
such as liquid chromatography-mass spectrometry (LC-
MS), gas chromatography-mass spectrometry (GC-MS) are 
extensively used for isotope ratio analysis with sufficient 
precision [42]. Hence, LC-MS and NMR (Nuclear 
Magnetic Resonance) methods were used in this research 
work to examine the effect of Biofield Energy Healing 
Treatment on structural properties of the Biofield Energy 
Treated and untreated magnesium gluconate. Consequently, 
the authors sought to explore the impact of The Trivedi 
Effect
®
 - Energy of Consciousness Healing Treatment on 
the isotopic abundance ratios of PM+1/PM and PM+2/PM in 
magnesium gluconate through LC-MS based isotopic 
abundance ratio analysis in both the Biofield Energy 
Treated and untreated samples. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Magnesium gluconate hydrate was purchased from Tokyo 
Chemical Industry Co., Ltd. (TCI), Japan. All other 
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chemicals used in the experiment were of analytical grade 
available in India. 
2.2. Energy of Consciousness Healing Treatment 
Strategies 
Magnesium gluconate was one of the components of 
the new proprietary herbomineral formulation, which was 
developed by our research team and was used per se as 
the test compound for the current study. The test 
compound was divided into two parts, one part of the test 
compound did not receive any sort of treatment and was 
defined as the untreated or control magnesium gluconate 
sample. The second part of the test compound was 
subjected to The Trivedi Effect
®
 - Energy of 
Consciousness Healing Treatment (Biofield Energy 
Healing Treatment) by a group of twenty renowned 
Biofield Energy Healers remotely and was denoted as the 
Biofield Energy Treated or The Trivedi Effect
®
 Treated 
sample. Fifteen Biofield Energy Healers were remotely 
located in the U.S.A., two in Canada, one in the UK, one 
in Australia, and one in Germany. The test compound was 
located in the research laboratory of GVK Biosciences 
Pvt. Ltd., Hyderabad, India. The Trivedi Effect
®
 - Energy 
of Consciousness Healing Treatment (Biofield Energy 
Healing Treatment) was provided for 5 minutes through 
the Healer’s Unique Energy Transmission process 
remotely to the test compound, which was kept under 
laboratory conditions. None of the Biofield Energy 
Healers in this study visited the laboratory in person, nor 
had any contact with the compounds. Similarly, the 
control compound was subjected to “sham” healer for 5 
minutes, under the same laboratory conditions. The sham 
healer did not have any knowledge about the Biofield 
Energy Treatment. After that, The Trivedi Effect
®
 Treated 
and untreated samples were kept in similar sealed 
conditions and characterized thoroughly by LC-MS and 
NMR spectroscopy. 
2.3. Liquid Chromatography Mass Spectrometry (LC-MS) 
Analysis 
Liquid chromatography was performed using The 
Waters
®
 ACQUITY UPLC, Milford, MA, USA equipped 
with a binary pump (The Waters
®
 BSM HPLC pump), 
autosampler, column heater and a photo-diode array 
(PDA) detector. The column used for the study was a 
reversed phase Acquity BEH shield RP C18 (150 X 3.0 
mm, 2.5 µm). The column temperature was kept constant 
at 40˚C. The mobile phase was 2mM ammonium acetate 
in water as mobile phase A and acetonitrile as mobile 
phase B. Chromatographic separation was achieved with 
following gradient program: 0 min – 5%B; 1 min – 5%B; 
15 min - 97%B; 20 min – 97%B; 21 min – 5%B; 25 min – 
5%B. The flow rate was at a constant flow rate of 0.4 
mL/min. The control and Biofield Energy Treated 
samples were dissolved in a mixture of water and 
methanol (60:40 v/v) to prepare a 1 mg/mL stock 
solution. An aliquot of 2 µL of the stock solution was 
used for analysis by LC-ESI-MS and the total run time 
was 25 min. 
Mass spectrometric analysis was accompanied on a 
Triple Quad (Waters Quattro Premier XE, USA) mass 
spectrometer equipped with an electrospray ionization 
(ESI) source with the following parameters: electrospray 
capillary voltage 3.5 kV; source temperature 100˚C; 
desolvation temperature 350˚C; cone voltage 30 V; 
desolvation gas flow 1000 L/h and cone gas flow 60 L/h. 
Nitrogen was used in the electrospray ionization source. 
The multiplier voltage was set at 650 V. LC-MS was 
taken in positive ionization mode and with the full scan 
(m/z 50-1400). The total ion chromatogram, % peak area 
and mass spectrum of the individual peak (appeared in 
LC) were recorded. 
2.4. Isotopic Abundance Ratio Analysis 
The relative intensity of the peak in the mass spectra is 
directly proportional to the relative isotopic abundance of 
the molecule and the isotopic abundance ratio analysis 
was followed by the scientific literature reported [36-39] 
method described as below: 
PM stands for the relative peak intensity of the parent 
molecular ion [M
+
] expressed in percentage. In other way, 
it indicates the probability to A elements having only one 
natural isotope in appreciable abundance (for e.g. 
12
C, 
1
H, 
16
O, 
24
Mg, etc.) contributions to the mass of the parent 
molecular ion [M
+
]. 
PM+1 represents the relative peak intensity of the 
isotopic molecular ion [(M+1)
+
] expressed in percentage 
= (no. of 
13
C x 1.1%) + (no. of 
15
N x 0.40%) + (no. of 
2
H 
x 0.015%) + (no. of 
17
O x 0.04%) + (no. of 
25
Mg x 
12.66%) 
i.e. the probability to A + 1 elements having an isotope 
that has one mass unit heavier than the most abundant 
isotope (for e.g. 
13
C, 
2
H, 
17
O, 
25
Mg, etc.) contributions to 
the mass of the isotopic molecular ion [(M+1)
+
]. 
PM+2 represents the relative peak intensity of the 
isotopic molecular ion [(M+2)
+
] expressed in the 
percentage 
= (no. of 
18
O x 0.20%) + (no. of 
26
Mg x 13.94%) 
i.e. the probability to have A + 2 elements having an 
isotope that has two mass unit heavier than the most 
abundant isotope (for e.g. 
18
O, 
26
Mg, etc.) contributions to 
the mass of isotopic molecular ion [(M+2)
+
]. 
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Table 1. The isotopic composition (i.e. the natural isotopic abundance) of the elements. 
Element Symbol Mass % Natural Abundance A+1 Factor A+2 Factor 
Hydrogen 1H 1 99.9885   
 2H 2 0.0115 0.015nH  
Carbon 12C 12 98.892   
 13C 13 1.108 1.1 nC  
Oxygen 16O 16 99.762   
 17O 17 0.038 0.04 nO  
 18O 18 0.200  0.20 nO 
Magnesium 24Mg 24 78.99   
 25Mg 25 10.00 12.66 nMg  
 26Mg 26 11.01  13.94 nMg 
 
A represents element, n represents the number of the 
element (i.e. C, H. O, Mg, etc.) 
The value of the natural isotopic abundance of the 
elements used here for the theoretical calculation are 
achieved from the scientific literature and are presented in 
the Table 1 [43, 44]. 
Isotopic abundance ratio for A + 1 elements = PM+1/PM 
Similarly, isotopic abundance ratio for A + 2 elements = 
PM+2/PM 
Percentage (%) change in isotopic abundance ratio =  
[(IARTreated – IARControl)/ IARControl) x 100]              (1) 
Where, IARTreated = isotopic abundance ratio in the treated 
sample and IARControl = isotopic abundance ratio in the 
control sample. 
2.5. Nuclear Magnetic Resonance (NMR) Analysis 
1
H NMR spectra were recorded in a 400 MHZ VARIAN 
FT-NMR spectrometer at room temperature. Data refer to 
solutions in D2O with the residual solvent protons as internal 
references. 
1
H NMR multiplicities were designated as singlet 
(s), doublet (d), triplet (t), multiplet (m), and broad (br). 
13
C 
NMR spectra were measured at 100 MHz on a VARIAN FT-
NMR spectrometer at room temperature. Chemical shifts (δ) 
were in parts per million (ppm) relative to the solvent’s 
residual proton chemical shift (D2O, δ = 4.65 ppm) and 
solvent’s residual carbon chemical shift (D2O, δ = 0 ppm). 
3. Results and Discussion 
3.1. Liquid Chromatography-Mass Spectrometry (LC-MS) 
Analysis 
A sharp and narrow peak was found in both the liquid 
chromatograms of the control and treated magnesium 
gluconate (Figure 1) at the retention time (Rt) of 1.52 min 
indicating that the polarity/affinity of the treated sample 
remained identical compared to the control sample. The ESI-
MS spectra of both the control and treated magnesium 
gluconate at Rt of 1.52 min (Figure 2) showed the presence 
of the mass of magnesium gluconate at m/z 415 [M + H]
+
 
(calcd for C12H23MgO14
+
, 415). 
 
Figure 1. Liquid chromatograms of the control and Biofield Energy Treated magnesium gluconate. 
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Figure 2. The ESI-MS spectra of the control and Biofield Energy Treated magnesium gluconate. 
The notable fragment ion peaks in the lower m/z region of 
the molecular ion peak at m/z 415 were observed in the 
control sample at m/z 402, 380, 360, 343, 320, 307, 279, 
271, 255, 225, 213, 206, 183, 165, 142, 135, 114, and 100 
which correspond to the following molecular formula 
C12H26MgO13
4+
, C12H20MgO12
+
, C12H16MgO11
2+
, 
C12H15MgO10
+
, C10H16MgO10
+
, C9H15MgO10
+
, C9H3MgO9
•2+
, 
C9H11MgO8
+
, C9H11MgO7
+
, C8H9MgO6
+
, C7H9MgO6
+
, 
C8H6MgO5
2+
, C6H7MgO5
+
, C5H9O6
+
, C5H2O5
2+
, C5H11O4
+
, 
C5H6O3
2+
, and C4H4O3
2+
, respectively as shown in the Figure 
3. Consequently, the treated sample exhibited the fragment 
ion peaks at m/z 403, 379, 361, 343, 320, 307, 279, 254, 225, 
213, 206, 183, 165, 142, 135, 114, and 100 corresponding to 
the molecular formula C12H27MgO13
5+
, C12H19MgO12
+
, 
C12H17MgO11
+
, C12H15MgO10
+
, C10H16MgO10
+
, 
C9H15MgO10
+
, C9H3MgO9
2+
, C9H10MgO7
2+
, C8H9MgO6
+
, 
C7H9MgO6
+
, C8H6MgO5
2+
, C6H7MgO5
+
, C5H9O6
+
, C5H2O5
2+
, 
C5H11O4
+
, C5H6O3
2+
, and C4H4O3
2+
, respectively (Figure 3). 
 
Figure 3. Proposed fragmentation pattern of magnesium gluconate. 
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The ESI-MS spectra of the control and treated samples 
(Figure 2) exhibited almost similar type fragmentation 
pattern. The fragment ion peak at m/z 165 corresponding to 
C5H9O6
+
 displayed 100% relative peak intensity in the ESI-
MS spectrum of the control sample, while the highest 
intense peak was found in the ESI-MS spectrum of the 
treated sample at m/z 114 corresponding to C5H6O3
2+
 (Figure 
2). The relative peak intensities of the other ion peaks in The 
Trivedi Effect
®
 Treated sample were significantly changed 
compared with the control sample. 
3.2. Isotopic Abundance Ratio Analysis 
The molecular formula of magnesium gluconate is 
C12H22MgO14. LC-MS spectra of both the control and 
treated samples indicated the presence of the mass for 
protonated molecular ion at m/z 415 (C12H23MgO14
+
) 
showing 28.56% and 26.84% relative intensity, 
respectively. The theoretical calculation of PM+1 and PM+2 
for the protonated magnesium gluconate in the control 
sample was presented as below: 
P (
13
C) = [(12 x 1.1%) x 28.56% (the actual size of the M
+
 
peak)] / 100% = 3.77% 
P (
2
H) = [(23 x 0.015%) x 28.56%] / 100%= 0.10% 
P (
17
O) = [(14 x 0.04%) x 28.56%] / 100% = 0.16% 
P (
25
Mg) = [(1 x 12.66%) x 28.56%] / 100% = 3.62% 
PM+1 i.e. 
13
C, 
2
H, 
17
O, and 
25
Mg contributions from 
(C12H23MgO14)
+
 to m/z 416 = 7.65% 
From the above calculation, it has been found that 
13
C and 
25
Mg have major contribution to m/z 416. 
In the similar way, PM+2 can be calculated as follow: 
P (
18
O) = [(14 x 0.20%) x 28.56%] / 100% = 0.80% 
P (
26
Mg) = [(1 x 13.94%) x 28.56%] / 100% = 3.98% 
So, PM+2 i.e. 
18
O and 
26
Mg contributions from  
(C12H23MgO14)
+
 to m/z 417 = 4.78%. 
The above calculation indicated that 
13
C and 
25
Mg have 
the major contributions from magnesium gluconate to the 
isotopic peaks. 
PM = the relative peak intensity of the parent molecular 
ion [M
+
]; PM + 1 = the relative peak intensity of the isotopic 
molecular ion [(M+1)
+
], PM + 2 = the relative peak intensity 
of the isotopic molecular ion [(M+2)
+
], and M = mass of the 
parent molecule. 
LC-MS spectra of the control and treated samples 
indicated the presence of the mass for the protonated 
magnesium gluconate (m/z 415). Hence, PM, PM+1, and PM+2 
for magnesium gluconate at m/z 415, 416, and 417 of the 
control and treated samples were obtained from the observed 
relative peak intensities of [M
+
], [(M+1)
+
], and [(M+2)
+
] 
peaks, respectively in the respective ESI-MS spectra are 
presented in Table 2. The isotopic abundance ratio of 
PM+1/PM in the treated sample was significantly decreased by 
48.87% compared to the control sample (Table 2). 
Consequently, the percentage change in the isotopic 
abundance ratio of PM+2/PM was significantly increased by 
29.18% in the Biofield Energy Treated sample compared 
with the control sample. Thus, 
13
C, 
2
H, 
17
O, and 
25
Mg 
contributions from (C12H23MgO14)
+
 to m/z 416; 
18
O and 
26
Mg contributions from (C12H23MgO14)
+
 to m/z 417 in The 
Trivedi Effect
®
 Treated sample were significantly changed 
compared to the control sample. 
Table 2. Isotopic abundance analysis results of the magnesium gluconate 
ion in the control and Biofield Energy Treated sample. 
Parameter 
Control 
sample 
Biofield Energy 
Treated sample 
PM at m/z 415 (%) 28.56 26.84 
PM+1 at m/z 416 (%) 10.84 5.21 
PM+1/PM 0.3796 0.1941 
% Change of isotopic abundance ratio 
(PM+1/PM) with respect to the control sample 
 -48.87 
PM+2 at m/z 417 (%) 7.75 9.41 
PM+2/PM 0.2714 0.3506 
% Change of isotopic abundance ratio 
(PM+2/PM) with respect to the control sample 
 29.18 
Scientific literature [37-39, 45] reported that the 
vibrational energy is closely related with the reduced mass 
(µ) of the compound and the alteration of the vibrational 
energy can affect the several properties like 
physicochemical, thermal properties of the molecule. The 
relation between the vibrational energy and the reduced 
mass (µ) for a diatomic molecule is expressed as below [42, 
45]: 
 = 	                                   (2) 
Where, E0 = the vibrational energy of a harmonic 
oscillator at absolute zero or zero point energy 
f = force constant 
μ = reduced	mass = 		               (3) 
Where, ma and mb are the masses of the constituent 
atoms. 
Table 3. Possible isotopic bond and their effect in the vibrational energy in 
magnesium gluconate molecule. 
S. 
No. 
Probable 
isotopic bond 
Isotope 
type 
Reduced 
mass (µ) 
Zero point vibrational 
energy (E0) 
1 12C-12C Lighter 6.00 Higher 
2 13C-12C Heavier 6.26 Smaller 
3 1H-12C Lighter 0.92 Higher 
4 2H-12C Heavier 1.04 Smaller 
5 12C-16O Lighter 6.86 Higher 
6 13C-16O Heavier 7.17 Smaller 
7 12C-17O Heavier 7.03 Smaller 
8 12C-18O Heavier 7.20 Smaller 
9 16O-1H Lighter 0.94 Higher 
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S. 
No. 
Probable 
isotopic bond 
Isotope 
type 
Reduced 
mass (µ) 
Zero point vibrational 
energy (E0) 
10 16O-2H Heavier 1.78 Smaller 
11 24Mg-16O Lighter 9.60 Higher 
12 25Mg-16O Heavier 9.76 Smaller 
13 26Mg-16O Heavier 9.91 Smaller 
14 24Mg-17O Heavier 9.95 Smaller 
15 24Mg-18O Heavier 10.29 Smaller 
The alteration in the isotopic abundance ratios of 
13
C/
12
C 
for C-O; 
2
H/
1
H for C-H and O-H bonds; 
17
O/
16
O and 
18
O/
16
O 
for C-O bond; 
25
Mg/
24
Mg, 
26
Mg/
24
Mg, 
17
O/
16
O and 
18
O/
16
O 
for Mg-O bond have the significant impact on the ground 
state vibrational energy of the molecule due to the higher 
reduced mass (µ) as shown in the Table 3 that leads to the 
isotope effects of the molecule. 
Mass spectroscopic analysis of the several organic 
compounds revealed that the isotopic abundance of 
[M+1]
+
 and [M+2]
+
 ions were increased or decreased, 
thereby suggesting the change in number of neutrons in 
the molecule. It was then postulated to the alterations in 
atomic mass and atomic charge through possible 
mediation of neutrino oscillation [37-39, 46]. Thus, it is 
assumed that The Trivedi Effect
®
 - Energy of 
Consciousness Healing Treatment might offer the 
required energy for the neutrino oscillations. The changes 
of neutrinos inside the molecule in turn modified the 
particle size, chemical reactivity, density, thermal 
behavior, selectivity, binding energy, etc. [46]. The 
variation in the isotopic abundance ratio of one of the 
atoms in the reactants in a chemical reaction produces 
kinetic isotope effect. This effect is very useful to study 
the enzyme mechanism and also for understanding the 
enzymatic transition state that is helpful for designing 
enormously effective and specific inhibitors [42, 45, 47]. 
As magnesium is a vital cofactor for various enzymatic 
reactions, The Trivedi Effect
®
 Treated magnesium 
gluconate that had altered isotopic abundance ratio might 
be beneficial for the study of enzyme mechanism as well 
as support in the designing of novel potent enzyme 
inhibitors. 
3.3. Nuclear Magnetic Resonance (NMR) Analysis 
The 
1
H and 
13
C NMR spectra of the control and treated 
magnesium gluconate are presented in the Figures 4 and 5, 
respectively. 
 
Figure 4. The 1H NMR spectra of the control and Biofield Energy Treated magnesium gluconate. 
 
Figure 5. The 13C NMR spectra of the control and Biofield Energy Treated magnesium gluconate. 
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Table 4. 1H NMR and 13C NMR spectroscopic data of both the control and Biofield Energy Treated of magnesium gluconate. 
br- broad, s- singlet, d- doublet, and dd- doublet of doublet, * These assignments can be switched. 
NMR assignments of the control and Biofield Energy 
Treated magnesium gluconate are shown in the Table 4. 
Although magnesium gluconate contains a large number of 
hydroxyl (OH) groups, the proton spectra of both the control 
and treated samples did not show any signal for the hydroxyl 
protons due to the replacement of the hydroxyl protons by 
deuterium from deuterated water, which was used as solvent 
for spectra recording. The signals for the protons coupling of 
CH2 group and adjacent CH protons (2-5) in the gluconic 
acid portion were observed in the control in the range of δ 
3.47 to 4.03 ppm, these signals were found in the treated 
samples in the range of δ 3.45 to 4.01 ppm (Table 4), which 
was almost in accordance with the proton spectrum of 
sodium gluconate [48]. Similarly, the carbon signals for CO 
group, CH2 and CH groups in the 
13
C NMR spectrum of the 
treated sample were almost similar compared with the 
control sample (Table 4). So, the structure of the magnesium 
gluconate in the treated sample remained identical with the 
control sample. 
4. Conclusions 
The present study results demonstrated the structural 
characterization of magnesium gluconate using LC-MS and 
NMR techniques with a significant impact of The Trivedi 
Effect
®
 - Energy of Consciousness Healing Treatment on the 
isotopic abundance ratios of PM+1/PM and PM+2/PM. The LC-
MS analysis of the both control and treated samples showed 
the presence of the mass of the protonated magnesium 
gluconate at m/z 415 at the retention time of 1.52 min with 
almost same type of fragmentation. Subsequently, the 
relative peak intensities of the fragment ions of The Trivedi 
Effect
®
 Treated sample were significantly changed 
compared to the control sample. The isotopic abundance 
ratio of PM+1/PM (
2
H/
1
H or 
13
C/
12
C or 
17
O/
16
O or 
25
Mg/
24
Mg) 
was significantly decreased in the Biofield Energy Treated 
sample by 48.87% compared with the control sample. 
Consequently, the percentage change in the isotopic 
abundance ratio of PM+2/PM (
18
O/
16
O or 
26
Mg/
24
Mg) was 
significantly increased by 29.18% in the treated sample 
compared to the control sample. Briefly, 
13
C, 
2
H, 
17
O, and 
25
Mg contributions from (C12H23MgO14)
+
 to m/z 416; 
18
O 
and 
26
Mg contributions from (C12H23MgO14)
+
 to m/z 417 in 
the treated sample were significantly altered compared with 
the control sample. The treated sample might display isotope 
effects such as different physicochemical and thermal 
properties, rate of the reaction, selectivity and binding 
energy due to its altered isotopic abundance ratios of 
PM+1/PM and PM+2/PM compared to the control sample. The 
Trivedi Effect
®
 Treated magnesium gluconate might be 
supportive to understand the enzymatic reactions as well as 
to design the novel potent enzyme inhibitors using its kinetic 
isotope effects. Besides, The Trivedi Effect
®
- Energy of 
Consciousness Healing Treatment could be a useful 
approach for the design of better nutraceutical and/or 
pharmaceutical formulations that can provide significant 
therapeutic responses against various diseases such as 
diabetes mellitus, allergies and septic shock, stress-related 
disorders like sleep disorder, insomnia, anxiety, depression, 
Attention Deficit Disorder (ADD), Attention Deficit 
Hyperactive Disorder (ADHD), mental restlessness (mind 
chattering), brain frog, low libido, impotency, lack of 
motivation, mood swings, fear of the future, confusion, 
migraines, headaches, forgetfulness, overwhelm, loneliness, 
worthlessness, indecisiveness, frustration, irritability, 
chronic fatigue, obsessive/compulsive behavior and panic 
attacks, inflammatory diseases and immunological disorders 
like Lupus, Systemic Lupus Erythematosus, Hashimoto 
Thyroiditis, Type 1 Diabetes, Asthma, Chronic peptic ulcers, 
Tuberculosis, Hepatitis, Chronic active hepatitis, Celiac 
Disease (gluten-sensitive enteropathy), Addison Disease, 
Crohn's disease, Graves’ Disease, Pernicious and Aplastic 
Anemia, Sjogren Syndrome, Irritable Bowel Syndrome 
(IBS), Multiple Sclerosis, Rheumatoid arthritis, Chronic 
periodontitis, Ulcerative colitis, Chronic sinusitis, 
Myasthenia Gravis, Atherosclerosis, Vasculitis, Dermatitis, 
Diverticulitis, Rheumatoid Arthritis, Reactive Arthritis, 
Alopecia Areata, Psoriasis, Scleroderma, Fibromyalgia, 
Chronic Fatigue Syndrome and Vitiligo, aging-related 
diseases like cardiovascular disease, arthritis, cancer, 
Alzheimer’s disease, dementia, cataracts, osteoporosis, 
diabetes, hypertension, glaucoma, hearing loss, Parkinson’s 
Disease, Huntington’s Disease, Prion Disease, Motor 
Neurone Disease, Spinocerebellar Ataxia, Spinal muscular 
atrophy, Amyotrophic lateral sclerosis, Friedreich’s Ataxia 
and Lewy Body Disease, chronic infections and many more. 
Abbreviations 
A: Element; LC-MS: Liquid chromatography-mass 
spectrometry; M: Mass of the parent molecule; m/z: Mass-
to-charge ratio; n: Number of the element; NMR: Nuclear 
Position 1H NMR δ (ppm) 13C NMR δ (ppm) 
 Number Control Treated Control Treated 
1, 1ꞌ 4H* 
3.65 (br s), 3.61 (br s), 
62.48 62.45 
3.47 ( dd, J = 12, 4 Hz ) 3.45 ( dd, J =12, 4 Hz ) 
2, 2ꞌ 2H* 3.59 (br s) 3.56 (br s) 70.68 70.64 
3, 3ꞌ 2H* 3.61 (br s) 3.58 (br s) 71.00 70.96 
4, 4ꞌ 2H 3.88 (br s) 3.86 (br s) 72.21 72.13 
5, 5ꞌ 2H 4.03 (d, J = 4 Hz) 4.01 (d, J = 4 Hz) 73.89 73.84 
6, 6ꞌ --  -- 178.36 178.33 
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magnetic resonance spectroscopy; PM: The relative peak 
intensity of the parent molecular ion [M
+
]; PM+1: The relative 
peak intensity of isotopic molecular ion [(M+1)
+
]); PM+2: 
The relative peak intensity of isotopic molecular ion 
[(M+2)
+
]); Rt: Retention time. 
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